Risk factors for multidrug-resistant A. baumannii and P. aeruginosa infection in burn care unit
Abstract
Infection is a major cause of morbidity and mortality in burns patients. In spite of considerable advances in the treatment of burns, infection continues to pose the greatest danger to burn patients. We aimed to evaluate and present risk factors for multidrug resistant (MDR) Pseudomonas aeruginosa and Acinetobacter baumannii infections which are considered as a challenge to burns.From January 2009 to May 2011, a total of 465 patients hospitalized in Burn Care Unit were retrospectively reviewed including bacteria isolated and antibiotic susceptibility tests.The mean age of patients was 18.6 ±22.0 yr (median=6,1-87 yr). Use of invasive device, lenght of stay in hospital, Intensive care unit lenght of stay and percentage of Total Body Surface Area were statistically significant for MDR A. baumannii and P. aeruginosa. In logistic regression, length of stay and the invasive device usage were found as risk factors for MDR A. baumannii and P. aeruginosa. Strict rules to control infections, lower hospitalization period and reducing the invasive device usage are essential to keep MDR and Nosocomial infections (NIs) rates lowered or at least in a stable phase.
Keywords
Kaynakça
- References1. Branski LK, Al-Mousawi A, Rivero H, Jeschke MG, Sanford AP, Herndon DN. Emerging infections in burns. Surg Infect. 2009; 10:389–97.
- 2. Keen EF, Robinson BJ, Hospenthal DR, et al. Incidence and bacteriology of burn infections at a military burn center. Burns 2010; 36:461-8.
- 3. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance defini- tion of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36:309-32.
- 4. American College of Surgeons. Advanced trauma life support.6th ed. Chicago: American College of Surgeons; 1997.
- 5. Lund CC, Browder NC. The estimation of areas of burns. Surg Gynecol Obstet 1944; 79:352-8.
- 6. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disc susceptibility tests. CLSI Document M100-S12, 2002. CLSI, Wayne, PA.
- 7. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18:268–81.
- 8. Rafla K, Tredget E.E. Infection control in the burn unit. Burns 2011; 37:5-15.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Sağlık Kurumları Yönetimi
Bölüm
Araştırma Makalesi
Yayımlanma Tarihi
28 Mart 2019
Gönderilme Tarihi
15 Ocak 2019
Kabul Tarihi
18 Mart 2019
Yayımlandığı Sayı
Yıl 2019 Cilt: 41 Sayı: 1